NDC 31722-847 – Milnacipran Hydrochloride
Milnacipran Hydrochloride 25 mg/1 · Tablet, Film Coated · Oral
Product NDC31722-847
Product details
- Brand name
- Milnacipran Hydrochloride
- Generic name
- Milnacipran Hydrochloride
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- ANDA · ANDA205147
- Marketed since
- March 19, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Serotonin and Norepinephrine Reuptake Inhibitor
Active ingredients
- Milnacipran Hydrochloride 25 mg/1
Uses, dosage, side effects and warnings for Milnacipran Hydrochloride →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 31722-847-32 | 10 BLISTER PACK in 1 CARTON (31722-847-32) / 10 TABLET, FILM COATED in 1 BLISTER PACK | Mar 19, 2026 |
| 31722-847-60 | 60 TABLET, FILM COATED in 1 BOTTLE (31722-847-60) | Mar 19, 2026 |
Other Milnacipran Hydrochloride products
- 51991-034 Milnacipran Hydrochloride 12.5 mg/1 · Tablet · Breckenridge Pharmaceutical, Inc.
- 51991-036 Milnacipran Hydrochloride 50 mg/1 · Tablet · Breckenridge Pharmaceutical, Inc.
- 51991-037 Milnacipran Hydrochloride 100 mg/1 · Tablet · Breckenridge Pharmaceutical, Inc.
- 51991-876 Milnacipran Hydrochloride 25 mg/1 · Tablet · Breckenridge Pharmaceutical, Inc.
- 31722-846 Milnacipran Hydrochloride 12.5 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 31722-848 Milnacipran Hydrochloride 50 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 31722-849 Milnacipran Hydrochloride 100 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 31722-880 · Kit · Camber Pharmaceuticals, Inc.
- 68462-763 Milnacipran Hydrochloride 12.5 mg/1 · Tablet, Film Coated · Glenmark Pharmaceuticals Inc., USA
- 68462-764 Milnacipran Hydrochloride 25 mg/1 · Tablet, Film Coated · Glenmark Pharmaceuticals Inc., USA
- 68462-765 Milnacipran Hydrochloride 50 mg/1 · Tablet, Film Coated · Glenmark Pharmaceuticals Inc., USA
- 68462-766 Milnacipran Hydrochloride 100 mg/1 · Tablet, Film Coated · Glenmark Pharmaceuticals Inc., USA